10-K
XBRL
FORM 10-K
- Company
- ENANTA PHARMACEUTICALS INC
- Filed
- December 9, 2016
- Period of Report
- September 30, 2016
- Accession Number
- 0001193125-16-789660
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →